세계의 신장 이식 시장 보고서(2025년)
Kidney Transplant Global Market Report 2025
상품코드 : 1824288
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 신장 이식 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년까지 CAGR 5.2%로 확대되어 78억 6,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 이식 수요 증가, 면역조절 요법 개발, 생체 기증자 풀 확대, 대기 시간 최소화, 이식 전 평가를 위한 원격 의료 등에 기인할 수 있습니다. 예측기간의 주요 동향으로는 환자 중심의 케어 모델, 이종이식 조사, 거부반응 모니터링 강화, 이식 후 케어를 위한 원격의료, 이식에 대한 접근성 확대 등을 들 수 있습니다.

향후 5년간의 성장률 5.2%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 네덜란드와 인도에서 개발된 장기 관류 시스템 및 면역억제제의 가격을 상승시키고, 대기 시간의 장기화와 이식 수술비의 상승을 초래하여 미국의 이식 치료의 성과를 저해할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

예상되는 신장 장애와 신부전의 발생 증가는 향후 신장 이식 시장의 성장을 견인하는 요인입니다. 신장 장애와 신부전은 신장이 작동하지 않는 상태를 말하며, 체내 화학성분의 균형이 무너져 혈액으로부터 노폐물이나 여분의 수분을 배출할 수 없게 됩니다. 신장 이식은 신장 기능을 회복시키고 신부전의 근본 원인을 다루는 데 필요합니다. 2023년 미국 신장 기금에 따르면 3,700만명의 미국인이 신장병을 앓고, 2020년에는 약 13만명의 미국인이 새롭게 신부전으로 진단된다고 합니다. 그 결과 신장 장애와 신부전 발생률 증가는 신장 이식 시장 확대의 중요한 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

A kidney transplant is a surgical intervention involving the replacement of a diseased or non-functioning kidney with a healthy kidney from a donor. This procedure is considered as a treatment option for individuals facing end-stage kidney disease or severe kidney dysfunction that cannot be effectively managed through alternative therapies such as dialysis.

The primary types of kidney transplants include deceased-donor kidney transplants, living-donor kidney transplants, and expanded-criteria donor kidney transplants. In a deceased-donor kidney transplant, a kidney is obtained from a deceased donor and transplanted into a recipient experiencing end-stage renal disease (ESRD). This surgical procedure is conducted in both adult and pediatric patients and finds applications in areas such as drug delivery, capsule endoscopy, and patient monitoring. These procedures are carried out by various end users, including transplant centers, hospitals, and academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The kidney transplant research report is one of a series of new reports from The Business Research Company that provides kidney transplant market statistics, including the kidney transplant industry's global market size, regional shares, competitors with a kidney transplant market share, detailed kidney transplant market segments, market trends and opportunities, and any further data you may need to thrive in the kidney transplant industry. This kidney transplant market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The kidney transplant market size has grown steadily in recent years. It will grow from $6.15 billion in 2024 to $6.42 billion in 2025 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to research and clinical trials, patient education and support, enhanced diagnostic tools, advancements in post-transplant care, immunosuppressive therapies.

The kidney transplant market size is expected to see strong growth in the next few years. It will grow to $7.86 billion in 2029 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to increasing demand for transplantation, development of immunomodulatory therapies, expansion of living donor pool, minimization of wait times, telemedicine for pre-transplant evaluation. Major trends in the forecast period include patient-centric care models, research in xenotransplantation, enhanced rejection monitoring, telemedicine for post-transplant care, expanded access to transplantation.

The forecast of 5.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. transplant outcomes by inflating prices of organ perfusion systems and immunosuppressant drugs developed in the Netherlands and India, resulting in longer waitlist times and higher transplant surgery expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated increase in the occurrence of renal disorders and kidney failure is poised to drive the growth of the kidney transplant market in the future. Renal disorders and kidney failure refer to conditions where the kidneys cease to function, leading to an imbalance in bodily chemicals and the inability to eliminate waste and excess water from the blood. Kidney transplants become a necessity to restore kidney function and address the underlying causes of renal failure. According to the American Kidney Fund in 2023, 37 million Americans suffer from kidney disease, with approximately 130,000 Americans newly diagnosed with kidney failure in 2020. Consequently, the growing incidence of renal disorders and kidney failure serves as a significant driver for the expansion of the kidney transplant market.

The anticipated shortage of donor organs is expected to fuel the growth of the kidney transplant market. This shortage arises when the supply of available organs for transplantation falls short of the demand. The scarcity of donor organs intensifies the demand for kidney transplants, representing a critical and often life-saving intervention for individuals with kidney disorders. Life Source reported in March 2023 that every day, 17 individuals die while waiting for an organ transplant, and a new name is added to the transplant waiting list every 9 minutes. Currently, over 100,000 patients in the US are awaiting a second chance at a life-saving organ transplant. Thus, the shortage of donor organs acts as a driving force behind the expansion of the kidney transplant market.

Advancements in kidney transplantation techniques emerge as a noteworthy trend gaining traction in the kidney transplant market. Companies within the industry are dedicating efforts to developing innovative solutions for kidney transplants to maintain their competitive positions. Stanford Medicine, a US-based healthcare system, introduced the DISOT (dual immune/solid organ transplant) technique in June 2022 for pediatric kidney transplantation. This groundbreaking method involves transferring the donor's immune system to the recipient before the kidney transplant, eliminating the need for lifelong immune-suppressing drugs. The innovation brings significant benefits to patients by sparing them from the serious long-term side effects associated with immune-suppressing medications, including increased risks of cancer, diabetes, infections, and hypertension.

Major companies in the kidney transplant sector are adopting strategic partnerships to enhance the overall patient experience and provide more comprehensive solutions. Strategic partnerships involve companies leveraging each other's strengths and resources for mutual benefits and success. For example, in April 2023, CareDx Inc., a US-based biotechnology research company, partnered with Miromatrix Medical Inc., a US-based life sciences company. This collaboration aims to expedite the development of bioengineered organs for human transplantation, combining expertise, resources, and market reach to contribute significantly to addressing the organ shortage crisis and improving the lives of transplant patients globally.

In January 2022, DaVita Inc., a US-based kidney dialysis services company, acquired MedSleuth Inc. for an undisclosed amount. Through this acquisition, DaVita Inc. seeks to alleviate access burdens on kidney and liver transplant candidates by connecting them to transplant centers, physicians, and care teams to enhance kidney and liver transplant outcomes. MedSleuth Inc., a US-based transplant software company, provides kidney transplantation technology services.

Major companies operating in the kidney transplant market include Pfizer Inc., Novartis AG, B. Braun Melsungen AG, Fresenius Medical Care AG & Co., Medtronic Plc., TransMedics Inc., Preservation Solution Inc., Organ Recovery Systems Inc., Transonic Systems Inc., DaVita Inc., Glycorex Transplantation AB, Astellas Pharma Inc., Veloxis Pharmaceuticals A/s, Immucor Inc., Penn Medicine, Sanofi S.A, Amgen Inc., Amyndas Pharmaceuticals, Abbvie Inc., Teva Pharmaceuticals Ltd., BiolifeSolutions, Bristol-Myers Squibb Company, CareDx Inc., CSL Behring, Grifols S.A., Kedrion Biopharma Inc.

North America was the largest region in the kidney transplant market in 2024. Europe is expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the kidney transplant market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The kidney transplant market includes revenues earned by entities by providing post-transplant care and monitoring services, dialysis services, rehabilitation services, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Kidney Transplant Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kidney transplant market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for kidney transplant ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The kidney transplant market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Kidney Transplant Market Characteristics

3. Kidney Transplant Market Trends And Strategies

4. Kidney Transplant Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Kidney Transplant Growth Analysis And Strategic Analysis Framework

6. Kidney Transplant Market Segmentation

7. Kidney Transplant Market Regional And Country Analysis

8. Asia-Pacific Kidney Transplant Market

9. China Kidney Transplant Market

10. India Kidney Transplant Market

11. Japan Kidney Transplant Market

12. Australia Kidney Transplant Market

13. Indonesia Kidney Transplant Market

14. South Korea Kidney Transplant Market

15. Western Europe Kidney Transplant Market

16. UK Kidney Transplant Market

17. Germany Kidney Transplant Market

18. France Kidney Transplant Market

19. Italy Kidney Transplant Market

20. Spain Kidney Transplant Market

21. Eastern Europe Kidney Transplant Market

22. Russia Kidney Transplant Market

23. North America Kidney Transplant Market

24. USA Kidney Transplant Market

25. Canada Kidney Transplant Market

26. South America Kidney Transplant Market

27. Brazil Kidney Transplant Market

28. Middle East Kidney Transplant Market

29. Africa Kidney Transplant Market

30. Kidney Transplant Market Competitive Landscape And Company Profiles

31. Kidney Transplant Market Other Major And Innovative Companies

32. Global Kidney Transplant Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Kidney Transplant Market

34. Recent Developments In The Kidney Transplant Market

35. Kidney Transplant Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기